Cargando…
Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?
BACKGROUND: Diagnosis of C. difficile infection (CDI) is controversial because of the many laboratory methods available and their lack of ability to distinguish between carriage, mild or severe disease. Here we describe whether a low C. difficile toxin B nucleic acid amplification test (NAAT) cycle...
Autores principales: | Garvey, Mark I., Bradley, Craig W., Wilkinson, Martyn A. C., Holden, Elisabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735516/ https://www.ncbi.nlm.nih.gov/pubmed/29270290 http://dx.doi.org/10.1186/s13756-017-0283-z |
Ejemplares similares
-
2366. PCR Followed by Toxin EIA for the Diagnosis of C. difficile Infection
por: Zhang, Yu, et al.
Publicado: (2019) -
Clinical Characteristics and Outcomes of Hematologic Malignancy Patients with Clostridium difficile Toxin EIA vs. PCR Positive Test Results
por: Ziegler, Matthew, et al.
Publicado: (2017) -
Clinical Correlation of a Clostridium difficile Testing Algorithm Reflexing PCR Positive Specimens to Toxin Enzyme Immunoassay (EIA)
por: Rios, Maria Bueno, et al.
Publicado: (2017) -
699. Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridium difficile Infection: A Systematic Review and Meta-Analysis
por: Prosty, Connor, et al.
Publicado: (2023) -
Differences in Clinical Characteristics and Outcomes of Patients with Community-Onset Clostridium difficile Infection who Tested Positive by EIA Compared with NAAT through a Two-Step Algorithm
por: Phipps, Erin C, et al.
Publicado: (2017)